Stem cells in sepsis and acute lung injury
Authors:
- Sushma K. CribbsSCSushma K. Cribbs
- Michael A. MatthayMMMichael A. Matthay
- Greg S. MartinGMGreg S. Martin
- 1 December 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 38 (12) , 2379-2385
Abstract
Objective: Sepsis and acute lung injury continue to be major causes of morbidity and mortality worldwide despite advances in our understanding of pathophysiology and the discovery of new management strategies. Recent investigations show that stem cells may be beneficial as prognostic biomarkers and novel therapeutic strategies in these syndromes. This article reviews the potential use of endogenous adult tissue-derived stem cells in sepsis and acute lung injury as prognostic markers and also as exogenous cell-based therapy. Data Sources: A directed systematic search of the medical literature using PubMed and OVID, with particular emphasis on the time period after 2002, was done to evaluate topics related to 1) the epidemiology and pathophysiology of sepsis and acute lung injury; and 2) the definition, characterization, and potential use of stem cells in these diseases. Data Synthesis and Findings: When available, preferential consideration was given to prospective nonrandomized clinical and preclinical studies. Conclusions: Stem cells have shown significant promise in the field of critical care both for 1) prognostic value and 2) treatment strategies. Although several recent studies have identified the potential benefit of stem cells in sepsis and acute lung injury, further investigations are needed to more completely understand stem cells and their potential prognostic and therapeutic value.Keywords
This publication has 89 references indexed in Scilit:
- Acute Lung Injury but Not Sepsis Is Associated with Increased Colony Formation by Peripheral Blood Mononuclear CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosisRespiratory Research, 2010
- Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lungProceedings of the National Academy of Sciences, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injuryProceedings of the National Academy of Sciences of the United States of America, 2007
- Working hypothesis to redefine endothelial progenitor cellsLeukemia, 2007
- Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principalsBlood, 2006
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- Human Pulmonary Chimerism after Hematopoietic Stem Cell TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem CellCell, 2001